CLINICAL_TRIALS
trial_result
· 2016-07-26
Clinical Trial Update: Hydroxychloroquine in Untreated B-CLL Patients [Phase 2]
Summary
A Phase 2 trial evaluating hydroxychloroquine in untreated B-cell chronic lymphocytic leukemia was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwell Health | Conditions: B-Cell Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2016-07-26